BUB1B and skin cancer: In addition, it has been reported that the overall pattern of BubR1 localisation, revealed by immunostaining, differed between normal and malignant tissues in bladder, colon, pancreas, and skin cancers (Shin et al, 2003; Yamamoto et al, 2007; Burum-Auensen et al, 2007b).